type 2 diabetes GSK cardiovascular disease
GSK reports positive results from Harmony Outcomes albiglutide trial
GlaxoSmithKline (GSK) has reported positive results from the Phase lV Harmony Outcomes trial evaluating the effect of albiglutide on major…